MEI Pharma Newsroom

Laidlaw Cuts MEI Pharma to Hold Over Shutdown Concerns

Seeking AlphaJul 23 16:19 ET

MEI Pharma Analyst Ratings

BenzingaJul 23 06:47 ET

Stifel Nicolaus Reaffirms Their Hold Rating on MEI Pharma (MEIP)

TipRanksMay 15 22:15 ET

MEI Pharma Analyst Ratings

BenzingaApr 12 11:51 ET

MEI Pharma Analyst Ratings

BenzingaFeb 14 08:59 ET

Stifel Nicolaus Reaffirms Their Hold Rating on MEI Pharma (MEIP)

TipRanksNov 14, 2023 21:05 ET

Stifel Maintains Hold on MEI Pharma, Lowers Price Target to $9

BenzingaSep 27, 2023 08:29 ET

MEI Pharma Analyst Ratings

BenzingaSep 27, 2023 08:28 ET

Brookline Capital Maintains Buy on MEI Pharma, Announces $80 Price Target

BenzingaMay 23, 2023 12:14 ET

Watching MEI Pharma; Hearing Brookline Capital Reiterates Buy Rating, $80 Price Target

BenzingaMay 23, 2023 11:47 ET

Stifel Adjusts MEI Pharma's Price Target to $10 From $0.50, Keeps Hold Rating

MT NewswiresMay 12, 2023 10:20 ET

Stifel Maintains Hold on MEI Pharma, Raises Price Target to $10

BenzingaMay 12, 2023 09:37 ET

BTIG Reaffirms Their Hold Rating on MEI Pharma (MEIP)

TipRanksFeb 14, 2023 06:00 ET

HC Wainwright Adjusts Price Target on MEI Pharma to $2 From $5, Maintains Buy Rating

MT NewswiresFeb 13, 2023 22:32 ET

Stifel Nicolaus Adjusts MEI Pharma Price Target to $0.50 From $2, Maintains Hold Rating

MT NewswiresFeb 13, 2023 22:25 ET

MEI Pharma Analyst Ratings

Benzinga Analyst RatingsFeb 13, 2023 06:18 ET

HC Wainwright & Co. Maintains Buy on MEI Pharma, Lowers Price Target to $2

Benzinga Real-time NewsFeb 13, 2023 06:18 ET

Brookline Capital Markets Reaffirms Their Buy Rating on MEI Pharma (MEIP)

TipRanksFeb 9, 2023 20:58 ET

Jefferies Downgrades MEI Pharma to Underperform, Lowers Price Target to $0.1

Benzinga Real-time NewsFeb 8, 2023 05:18 ET

MEI Pharma Analyst Ratings

Benzinga Analyst RatingsFeb 8, 2023 05:17 ET